Get the Stockscreener App
18.96
0.48%
0.09
After Hours:
18.81
-0.15
-0.79%
Beta Bionics Inc stock is traded at $18.96, with a volume of 515.07K.
It is up +0.48% in the last 24 hours and down -2.34% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
See More
Previous Close:
$18.87
Open:
$18.87
24h Volume:
515.07K
Relative Volume:
0.40
Market Cap:
$1.02B
Revenue:
$110.24M
Net Income/Loss:
$-66.44M
P/E Ratio:
-12.55
EPS:
-1.5111
Net Cash Flow:
$-61.12M
1W Performance:
-11.85%
1M Performance:
-2.34%
6M Performance:
+90.94%
1Y Performance:
-7.47%
1-Day Range:
$18.27
$19.26
1-Week Range:
$18.27
$21.70
52-Week Range:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
18.96 | 1.16B | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Jan-09-26 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors Wi - The National Law Review
Important Notice to Long-Term Shareholders of Beta Bionics, - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Securities Class Action Lawsuit Filed Against Beta Bionics, Inc. (BBNX)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Beta Bionics, Inc. (BBNX) stock price, news, quote and history - uk.finance.yahoo.com
רוזן, משרד מוביל בפריסה ארצית המייצג משקיעים, מעודד את משקיעי חברת Beta Bionics, Inc לשכור ייעוץ משפטי לקראת מועד אחרון חשוב במסגרת תביעה ייצוגית בניירות ערך – BBNX - GlobeNewswire Inc.
Beta Bionics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A NATIONAL AND LEADING INVESTOR RIGHTS FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. LawsuitBBNX - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Rosen Law urges Beta Bionics investors to act before Nov 3 deadline - scanx.trade
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application - GlobeNewswire
Robbins LLP Urges BBNX Stockholders to Contact the Firm for Information About the Class Action Against Beta Bionics, Inc. - PR Newswire
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX - FinancialContent
Beta Bionics, Inc. (BBNX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance -- HBSS - PR Newswire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal - TradingView
A 4:30 p.m. ET call will review Beta Bionics' third-quarter performance on Oct. 27. - Stock Titan
BBNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
BBNX Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
BBNX Investor Lawsuit: Beta Bionics Sued for Securities - GlobeNewswire
Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholde - The National Law Review
Class Action Lawsuit Filed: Beta Bionics, Inc. (BBNX) – Join by November 3, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
Faruqi & Faruqi, LLP Urges Beta Bionics (BBNX) Investors to Seek Counsel Before November 3, 2026 Lead Plaintiff Deadline in the Securities Class Action - TMX Newsfile
November 3, 2026 Deadline: Join Class Action Lawsuit Against Beta Bionics, Inc. (BBNX) – Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - newsfilecorp.com
Securities Class Action Lawsuit Filed Against Beta Bionics, Inc. (BBNX) – Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Investors Urged to Contact Levi & Korsinsky For Information Before November 3, 2026Beta Bionics, Inc. (BBNX) - ACCESS Newswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Morningstar
Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026 - FinancialContent
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Beta Bionics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investors in Beta Bionics, Inc. (BBNX): Protect Your RightsContact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Beta Bionics, Inc. (BBNX)Join by November 3, 2026Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: Beta Bionics, Inc. (BBNX) InvestorsContact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Levi & Korsinsky Urges Beta Bionics, Inc. (BBNX) Shareholders to Act Before Lead Plaintiff Deadline November 3, 2026 - ACCESS Newswire
Recover Investment Losses: Class Action Initiated Against Beta Bionics, Inc. (BBNX) - ACCESS Newswire
BBNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Class Action Lawsuit Filed Against Beta Bionics, Inc. (BBNX)Recover LossesContact Levi & Korsinsky Before November 3, 2026 - ACCESS Newswire
Beta Bionics (BBNX) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline - Eastern Progress
BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026 - ACCESS Newswire
Lost Money on Beta Bionics, Inc. (BBNX)? Contact Levi & Korsinsky to Join Class Action Before November 3, 2026 - ACCESS Newswire
Beta Bionics, Inc. (BBNX) Receives a Buy from Truist Financial - theglobeandmail.com
BBNX Stock Drop Alert: Beta Bionics Stock Plummets 37% - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Beta Bionics, Inc. (BBNX) Investors of November 3, 2026 Deadline - ACCESS Newswire
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):